138 related articles for article (PubMed ID: 31919415)
1. Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin.
Olatunji S; Yu X; Bailey J; Huang CY; Zapotoczna M; Bowen K; Remškar M; Müller R; Scanlan EM; Geoghegan JA; Olieric V; Caffrey M
Nat Commun; 2020 Jan; 11(1):140. PubMed ID: 31919415
[TBL] [Abstract][Full Text] [Related]
2. Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.
Xiao Y; Wall D
J Bacteriol; 2014 Mar; 196(6):1174-83. PubMed ID: 24391051
[TBL] [Abstract][Full Text] [Related]
3. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M
Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896
[TBL] [Abstract][Full Text] [Related]
5. Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.
Xiao Y; Gerth K; Müller R; Wall D
Antimicrob Agents Chemother; 2012 Apr; 56(4):2014-21. PubMed ID: 22232277
[TBL] [Abstract][Full Text] [Related]
6. LspA-independent action of globomycin on Mycobacterium tuberculosis.
Banaiee N; Jacobs WR; Ernst JD
J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235
[TBL] [Abstract][Full Text] [Related]
7. Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group IIA-Secreted Phospholipase A2 and Daptomycin.
Kuijk MM; Wu Y; van Hensbergen VP; Shanlitourk G; Payré C; Lambeau G; Man-Bovenkerk S; Herrmann J; Müller R; van Strijp JAG; Pannekoek Y; Touqui L; van Sorge NM
J Innate Immun; 2023; 15(1):333-350. PubMed ID: 36473432
[TBL] [Abstract][Full Text] [Related]
8. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in
Huang KJ; Pantua H; Diao J; Skippington E; Volny M; Sandoval W; Tiku V; Peng Y; Sagolla M; Yan D; Kang J; Katakam AK; Michaelian N; Reichelt M; Tan MW; Austin CD; Xu M; Hanan E; Kapadia SB
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2123117119. PubMed ID: 36099298
[No Abstract] [Full Text] [Related]
9. The lspA gene, encoding the type II signal peptidase of Rickettsia typhi: transcriptional and functional analysis.
Rahman MS; Ceraul SM; Dreher-Lesnick SM; Beier MS; Azad AF
J Bacteriol; 2007 Jan; 189(2):336-41. PubMed ID: 17098907
[TBL] [Abstract][Full Text] [Related]
10. Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).
Rishi P; Vij S; Maurya IK; Kaur UJ; Bharati S; Tewari R
Microb Pathog; 2018 Nov; 124():11-20. PubMed ID: 30118800
[TBL] [Abstract][Full Text] [Related]
11. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase.
Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D
ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of triosephosphate isomerase from methicillin resistant Staphylococcus aureus MRSA252 provide structural insights into novel modes of ligand binding and unique conformations of catalytic loop.
Mukherjee S; Roychowdhury A; Dutta D; Das AK
Biochimie; 2012 Dec; 94(12):2532-44. PubMed ID: 22813930
[TBL] [Abstract][Full Text] [Related]
13. [Genotyping and drug resistance of methicillin-resistant Staphylococcus aureus].
Yao M; Guan L; Jia W; Wang L; Li G; Wu X; Sun T
Zhonghua Shao Shang Za Zhi; 2014 Oct; 30(5):428-32. PubMed ID: 25572893
[TBL] [Abstract][Full Text] [Related]
14. Conformational dynamics of the membrane enzyme LspA upon antibiotic and substrate binding.
Caldwell TA; Vickery ON; Colburn JD; Stansfeld PJ; Columbus L
Biophys J; 2022 Jun; 121(11):2078-2083. PubMed ID: 35505611
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
[TBL] [Abstract][Full Text] [Related]
16. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
Adhikari RP; Shrestha S; Barakoti A; Amatya R
BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Azalomycin F
Xu L; Xu X; Yuan G; Wang Y; Qu Y; Liu E
Biomed Res Int; 2018; 2018():6942452. PubMed ID: 29607325
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
19. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
Aydeniz Ozansoy F; Cevahir N; Kaleli İ
Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
